Returning to the midkine and viral pneumonia discussion, which to my mind is much more interesting than whether CDY can make a few bucks out of test kits - does anyone remember how we are placed re manufacture of midkine antibodies? Are we in a position to supply them if demand takes off? That was the Kikkoman connection, wasn't it??
Or would we simply be licensing others to produce them for their own use?
Yes, I just opened the bottom drawer and got out my CDY shares. Gosh, are they ever dusty...
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-161
-
- There are more pages in this discussion • 1,110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1499234 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 381703 | 2 |
View Market Depth
| Last trade - 10.00am 12/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable